Unbound MEDLINE

Designing dendrimers for ocular drug delivery. European journal of medicinal chemistry [Eur J Med Chem] Journal article

 
TitleDesigning dendrimers for ocular drug delivery.
Author(s)Spataro G, Malecaze F, Turrin CO, Soler V, Duhayon C, Elena PP, Majoral JP, Caminade AM 
InstitutionCNRS, LCC (Laboratoire de Chimie de Coordination), 205 route de Narbonne, F-31077 Toulouse, France; Université de Toulouse, UPS, INPT; LCC, F-31077 Toulouse, France.
SourceEur J Med Chem 2009 Oct 14.
AbstractNew series of phosphorus-containing dendrimers, having one quaternary ammonium salt as core and carboxylic acid terminal groups have been synthesized from generation 0 (3 carboxylic acid terminal groups) to generation 2 (12 carboxylic acid terminal groups). These dendrimers react with the neutral form of carteolol (an ocular anti-hypertensive drug used to treat glaucoma) to afford ion pair (saline) species. The solubility in water of these charged dendrimers depends on the generation considered: generation 0 (3 carteolol) is well soluble, whereas generation 1 (6 carteolol) and generation 2 (12 carteolol) are poorly soluble. These dendrimers have been tested in vivo, as vehicle for ocular drug delivery of carteolol to rabbits.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19889480
  
Advertise on this site.